| Phenotype | Clinically significant cancer were any of: Gleason score ≥ 7, stage T3-T4, PSA concentration ≥ 10 ng/mL, pelvic lymph nodal metastasis or distant metastasis. |
| Sample Ancestry | African unspecified |
| Total number | 6,271 individuals |
| Detailed numbers |
3,031 cases (48.33%)
3,240 controls
100.0% Male samples
|
| Number of Cohort(s) | 18 |
| Cohort Short Name | Cohort Full Name | Previous/other/additional names (e.g. sub-cohorts) |
|---|---|---|
| BioVU | BioVU, the Vanderbilt DNA Databank project | — |
| CeRePP | French Prostate Cancer Case-Control Study | — |
| CPDR | Center for Prostate Disease Research | — |
| EPICAP | Epidemiology of Prostate Cancer | — |
| KARUPROSTATE | French West Indies Prostate cancer Study (from Karukera, the original Caribbean name of Guadeloupe) | — |
| MIAMI-WFPCS | The University of Miami – Sylvester Comprehensive Cancer Center | — |
| MOFFITT | The Moffitt Group | — |
| NMHS | Nashville Men's Health Study | — |
| PCaP | North Carolina-Louisiana Prostate Cancer Project Consortium | — |
| PCPT | Prostate Cancer Prevention Trial | SWOG-PCPT |
| PROtEuS | Prostate Cancer and Environment Study | — |
| SABOR | San Antonio Center of Biomarkers of Risk for Prostate Cancer | — |
| SCCS | NBHS/Southern Community Cohort | — |
| SCPCS | South Carolina Prostate Cancer Study | — |
| SELECT | Selenium and Vitamin E Cancer Prevention Trial | — |
| SFPCS | San Francisco Prostate Cancer Study | — |
| UKGPCS | UK Genetic Prostate Cancer Study | — |
| WUGS | Washington University Genetics Study | — |
PRACTICAL consortium